123 related articles for article (PubMed ID: 7445531)
1. Metabolism of ethynodiol diacetate in the rhesus monkey before and after administration of rifampicin.
Lewis CJ; Vose CW; Spalton PN; Ford GC; Haskins NJ; Palmer RF
Xenobiotica; 1980 Sep; 10(9):705-13. PubMed ID: 7445531
[TBL] [Abstract][Full Text] [Related]
2. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
Cameron BD; Draffan GH; Dunsire JP; Zimmer A
Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
[TBL] [Abstract][Full Text] [Related]
3. The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration.
Hackett AM; Griffiths LA; Broillet A; Wermeille M
Xenobiotica; 1983 May; 13(5):279-86. PubMed ID: 6636824
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
5. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
[TBL] [Abstract][Full Text] [Related]
6. The fate of saccharin impurities: the excretion and metabolism of [3-14C]Benz[d]-isothiazoline-1,1-dioxide (BIT) in man and rat.
Renwick AG; Williams RT
Xenobiotica; 1978 Aug; 8(8):475-86. PubMed ID: 695691
[TBL] [Abstract][Full Text] [Related]
7. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
[TBL] [Abstract][Full Text] [Related]
9. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
12. The disposition of [14C]iprindole in man, dog, miniature swine, rhesus monkey and rat.
Sisenwine SF; Tio CO; Ruelius HW
Xenobiotica; 1979 Apr; 9(4):237-46. PubMed ID: 113942
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of 14C-estazolam in dogs and humans.
Machinist JM; Bopp BA; Anderson DJ; Granneman GR; Sonders RC; Tolman K; Buchi K; Rollins D
Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
[TBL] [Abstract][Full Text] [Related]
14. The metabolic disposition of 14C-ciramadol in humans.
Sisenwine SF; Liu AL; Tio C; Kimmel H; Freeland G
Xenobiotica; 1986 Apr; 16(4):335-40. PubMed ID: 3754997
[TBL] [Abstract][Full Text] [Related]
15. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
16. Influence of Ethynodiol Diacetate on the Formation of A-Homo-3Oxa-5?-Pregnane-4,20-Dione in Female Rats.
Simic B; Kniewald J; Kniewald Z
Endocr Regul; 1998 Sep; 32(3):125-131. PubMed ID: 10196509
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey.
Hemeryck A; Mamidi RN; Bottacini M; Macpherson D; Kao M; Kelley MF
Xenobiotica; 2006 Jul; 36(7):597-613. PubMed ID: 16864506
[TBL] [Abstract][Full Text] [Related]
18. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
